Overview

Detailed Summary

Denis Chem Lab Ltd is a pharmaceutical company primarily focused on manufacturing sterile intravenous (IV) injectables and transfusion solutions.
The company leverages advanced Blow Fill Seal (BFS) technology to produce IV fluids in plastic bottles, reaching a capacity of 15 million units per annum by 2016.
In 2021, Denis Chem Lab expanded its production capacity for 100 ml Eurohead 'Aquapulse' products, adding 12,00,000 bottles per month.
The company operates a state-of-the-art manufacturing facility that adheres to WHO's GMP specifications, ensuring high-quality pharmaceutical products.
Denis Chem Lab's product portfolio includes antibiotic injections, diuretic injections, and plasma volume expanders, highlighting a wide range of specialized medical solutions.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 109 Cr
Volatility: Moderate Risk
P/E Ratio: 12.5
Industry P/E: 32.2
PEG Ratio: 1.4
P/B Ratio: 1.2
52W High: 114.85
52W Low: 56.10

Sales CAGR

1Y: 3.27%
3Y: 8.27%
5Y: 4.94%
10Y: 5.85%

Profit CAGR

1Y: -27.60%
3Y: 8.84%
5Y: 13.89%
10Y: —

ROE

TTM: 8.16%
3Y: 11.40%
5Y: 9.74%
10Y: 7.81%

ROCE

TTM: 14.50%
3Y: 15.95%
5Y: 13.91%
10Y: 13.50%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
GODAVARI		92.00	124 Cr	18.74	1.86	0.00	12.65	11.11	2.27
TYCHE		128.00	123 Cr	19.28	0.88	2.49	6.85	9.26	4.35
PAR		91.30	114 Cr	8.08	1.07	0.00	9.10	12.39	10.91
PHARMAID		30.00	109 Cr	-7.65	2.10	0.00	-31.40	-26.43	-15.53
DENISCHEM		78.80	109 Cr	12.55	1.24	1.91	8.16	14.50	7.05
VAISHALI		7.71	101 Cr	-2.73	1.50	0.00	-0.57	1.54	-0.43
ACCPL		73.50	96 Cr	8.67	2.14	0.00	19.50	25.71	15.37
Median: 7 Co.	—	78.80	109 Cr	8.67	1.50	0.00	8.16	11.11	4.35

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	45	40	40	41	48	43	41	43	46	46
Expenses	40	34	35	37	42	39	39	38	42	40
Operating Profit	5.14	5.99	5.07	4.35	5.88	3.82	2.05	4.81	4.26	6.02
OPM %	11.31	14.95	12.72	10.54	12.30	8.92	4.95	11.11	9.23	13.22
Other Income	0.52	0.26	0.59	0.32	0.58	0.30	1.17	0.30	0.65	0.44
Interest	0.09	0.13	0.23	0.12	0.09	0.07	0.23	0.19	0.23	0.22
Depreciation	1.76	1.84	1.75	1.63	1.66	1.84	1.73	1.61	1.65	1.83
Profit Before Tax	3.81	4.28	3.69	2.92	4.71	2.22	1.27	3.32	3.03	4.41
Tax %	33.07	25.23	26.02	28.77	25.05	20.72	44.09	25.30	26.73	24.72
Net Profit	2.54	3.20	2.73	2.08	3.53	1.76	0.71	2.48	2.21	3.32
EPS in Rs	1.83	2.31	1.97	1.50	2.54	1.27	0.51	1.78	1.60	2.39

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	118	108	124	136	109	137	161	168	173	175
Expenses	99	95	110	121	99	122	142	147	157	159
Operating Profit	19	13	14	15	10	14	19	21	16	17
OPM %	15.79	12.07	11.18	11.02	9.38	10.51	11.68	12.65	9.30	9.45
Other Income	0.65	0.53	1.66	0.28	0.35	1.05	0.59	1.39	2.37	2.35
Interest	5.80	4.61	3.25	2.89	1.55	0.76	0.64	0.54	0.51	0.58
Depreciation	6.77	5.93	6.36	6.66	5.96	5.76	7.82	6.95	6.86	6.84
Profit Before Tax	1.97	2.04	5.92	5.73	3.09	8.88	11	15	11	12
Tax %	37.10	-5.09	-7.23	26.41	26.65	29.50	28.00	26.28	27.32	26.39
Net Profit	1.24	2.14	6.35	4.21	2.26	6.26	7.86	11	8.08	8.48
EPS in Rs	0.59	1.69	4.56	3.03	1.63	4.52	5.67	8.04	5.82	6.28
Dividend Payout %	0.00	0.00	21.83	0.00	46.01	33.26	35.34	31.09	25.77	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	9.04	12	14	14	14	14	14	14	14	14
Reserves	7.41	18	36	43	45	48	53	58	66	71
Borrowings	36	33	21	19	11	8.62	3.22	1.93	1.05	0.82
Other Liabilities	32	31	30	30	28	22	27	25	28	26
Total Liabilities	85	94	101	106	97	92	96	99	109	112
Fixed Assets	40	44	40	50	46	41	42	35	38	39
CWIP	9.84	0.67	4.96	0.04	0.00	0.08	0.00	2.13	0.22	0.07
Investments	0.06	0.06	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	35	49	56	55	52	51	55	62	72	73
Total Assets	85	94	101	106	97	92	96	99	109	112

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	21	6.77	11	7.97	13	7.97	17	—	—	12
Cash from Investing Activity	-13	-1.30	-16	-1.78	-1.98	-1.13	-10	0.00	0.00	-8.23
Cash from Financing Activity	-6.98	-0.28	1.05	-5.37	-14	-5.51	-7.20	—	—	-4.21
Net Cash Flow	1.01	5.19	-4.38	0.82	-2.51	1.33	-0.27	0.00	0.00	-0.34

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%	38.98%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.01%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	61.02%	61.02%	61.02%	61.02%	61.02%	61.02%	61.02%	61.02%	61.01%	61.01%	61.01%	61.01%
Total Shareholders	3,723	4,635	4,794	4,834	6,021	6,857	7,385	7,218	7,227	7,304	7,102	6,927

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.